Literature DB >> 24658325

TCDD‑induced chick cardiotoxicity is abolished by a selective cyclooxygenase‑2 (COX‑2) inhibitor NS398.

Nozomi Fujisawa, Shouta M M Nakayama, Yoshinori Ikenaka, Mayumi Ishizuka.   

Abstract

Halogenated aromatic hydrocarbons, including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), are known to cause severe heart defects in avian species. However, the mechanism of TCDD-induced chick cardiovascular toxicity is unclear. In this study, we investigated cyclooxygenase-2 (COX-2) as a possible mechanism of TCDD-induced cardiotoxicity. Fertile chicken eggs were injected with TCDD and a COX-2 selective inhibitor, NS398, and we investigated chick heart failure on day 10. We found that the chick heart to body weight ratio and atrial natriuretic factor mRNA expression were increased, but this increase was abolished with treatment of NS398. In addition, the morphological abnormality of an enlarged ventricle resulting from TCDD exposure was also abolished with co-treatment of TCDD and NS398. Our results suggested that TCDD-induced chick heart defects are mediated via the nongenomic pathway and that they do not require the genomic pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24658325     DOI: 10.1007/s00204-014-1225-7

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  2 in total

1.  Protective effects of levamisole, acetylsalicylic acid, and α-tocopherol against dioxin toxicity measured as the expression of AhR and COX-2 in a chicken embryo model.

Authors:  Kinga Gostomska-Pampuch; Alicja Ostrowska; Piotr Kuropka; Maciej Dobrzyński; Piotr Ziółkowski; Artur Kowalczyk; Ewa Łukaszewicz; Andrzej Gamian; Ireneusz Całkosiński
Journal:  Histochem Cell Biol       Date:  2016-12-10       Impact factor: 4.304

Review 2.  Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?

Authors:  Rebeca Santes-Palacios; Diego Ornelas-Ayala; Noel Cabañas; Ana Marroquín-Pérez; Alexis Hernández-Magaña; Sitlali Del Rosario Olguín-Reyes; Rafael Camacho-Carranza; Jesús Javier Espinosa-Aguirre
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.